Form 8-K · Current Report · Filed 2024-06-06
The Cigna Group Reaffirms 2024 Earnings Outlook and Completes Share Repurchase
The Cigna Group has affirmed its projected full-year 2024 consolidated adjusted income from operations of at least $28.40 per share and has completed a $3.2 billion share repurchase program, repurchasing $4.4 billion of its common stock as of May 31, 2024.
- Filer
- The Cigna Group CI · NYSE
- Filed
- Accession
- 0000950159-24-000212
- CIK
- 0001739940
- Signal
- Low impactHealthcare
- Source
- Official filing on sec.gov ↗
Details
The company remains on track to repurchase $5.0 billion of common stock in the first half of 2024, with plans to use the majority of discretionary cash flow for share repurchases this year.
Items reported
Regulation FD Disclosure
Market reaction
Close before filing
$334.18
Next session
+1.2%
Since filing
-16.5%
Latest close
$279.05
What happened, not what will happen — closing prices around the filing date.
Precedent
Previous filings from CI reporting the same item, with the next session's move:
About The Cigna Group
The Cigna Group is a leading global health services organization. Ranging across a comprehensive spectrum of health and wellness services, the company aims to improve the health, well-being, and peace of mind of those it serves. Notably, Cigna offers medical, dental, disability, life, and accident insurance coverage to individuals and businesses, extending its reach from individual clients to multinational corporations. Its primary business comprehends a vast network within the managed care sector, focusing on providing accessible and affordable healthcare solutions to its users. Cigna’s influence spans multiple sectors including health insurance, pharmacy benefit management, and behavioral health, highlighting its diverse portfolio. The company plays a crucial role in the health insurance market, consistently driving innovation in healthcare solutions and cost management. Its ability to integrate health services and provide holistic care solutions is pivotal in addressing the evolving needs of the healthcare landscape globally."}
Never miss another CI filing
Profitelligence watches EDGAR around the clock and alerts you within seconds.